Literature DB >> 26272612

A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.

Feihan F Dai1, Alpana Bhattacharjee1, Ying Liu1, Battsetseg Batchuluun1, Ming Zhang1, Xinye Serena Wang1, Xinyi Huang1, Lemieux Luu1, Dan Zhu1, Herbert Gaisano1, Michael B Wheeler2.   

Abstract

GLP1 activates its receptor, GLP1R, to enhance insulin secretion. The activation and transduction of GLP1R requires complex interactions with a host of accessory proteins, most of which remain largely unknown. In this study, we used membrane-based split ubiquitin yeast two-hybrid assays to identify novel GLP1R interactors in both mouse and human islets. Among these, ATP6ap2 (ATPase H(+)-transporting lysosomal accessory protein 2) was identified in both mouse and human islet screens. ATP6ap2 was shown to be abundant in islets including both alpha and beta cells. When GLP1R and ATP6ap2 were co-expressed in beta cells, GLP1R was shown to directly interact with ATP6ap2, as assessed by co-immunoprecipitation. In INS-1 cells, overexpression of ATP6ap2 did not affect insulin secretion; however, siRNA knockdown decreased both glucose-stimulated and GLP1-induced insulin secretion. Decreases in GLP1-induced insulin secretion were accompanied by attenuated GLP1 stimulated cAMP accumulation. Because ATP6ap2 is a subunit required for V-ATPase assembly of insulin granules, it has been reported to be involved in granule acidification. In accordance with this, we observed impaired insulin granule acidification upon ATP6ap2 knockdown but paradoxically increased proinsulin secretion. Importantly, as a GLP1R interactor, ATP6ap2 was required for GLP1-induced Ca(2+) influx, in part explaining decreased insulin secretion in ATP6ap2 knockdown cells. Taken together, our findings identify a group of proteins that interact with the GLP1R. We further show that one interactor, ATP6ap2, plays a novel dual role in beta cells, modulating both GLP1R signaling and insulin processing to affect insulin secretion.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cyclic AMP (cAMP); insulin secretion; receptor; receptor-interacting protein (RIP); yeast two-hybrid

Mesh:

Substances:

Year:  2015        PMID: 26272612      PMCID: PMC4599009          DOI: 10.1074/jbc.M115.648592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  The cell biology of the prohormone convertases PC1 and PC2.

Authors:  L Muller; I Lindberg
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1999

2.  Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

Authors:  George G Sokos; Lazaros A Nikolaidis; Sunil Mankad; Dariush Elahi; Richard P Shannon
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

3.  A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo.

Authors:  I Stagljar; C Korostensky; N Johnsson; S te Heesen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Probing the molecular environment of membrane proteins in vivo.

Authors:  S Wittke; N Lewke; S Müller; N Johnsson
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

5.  GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.

Authors:  Charles Pyke; R Scott Heller; Rikke K Kirk; Cathrine Ørskov; Steffen Reedtz-Runge; Peter Kaastrup; Anders Hvelplund; Linda Bardram; Dan Calatayud; Lotte Bjerre Knudsen
Journal:  Endocrinology       Date:  2014-01-27       Impact factor: 4.736

6.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

Authors:  M B Wheeler; M Lu; J S Dillon; X H Leng; C Chen; A E Boyd
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

8.  Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling.

Authors:  Cristina-Maria Cruciat; Bisei Ohkawara; Sergio P Acebron; Emil Karaulanov; Carmen Reinhard; Dierk Ingelfinger; Michael Boutros; Christof Niehrs
Journal:  Science       Date:  2010-01-22       Impact factor: 47.728

9.  Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.

Authors:  Noriyuki Sonoda; Takeshi Imamura; Takeshi Yoshizaki; Jennie L Babendure; Juu-Chin Lu; Jerrold M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

10.  Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic β Cells: ROLES IN REGULATING CYTOSOLIC ZINC HOMEOSTASIS AND INSULIN SECRETION.

Authors:  Ying Liu; Battsetseg Batchuluun; Louisa Ho; Dan Zhu; Kacey J Prentice; Alpana Bhattacharjee; Ming Zhang; Farzaneh Pourasgari; Alexandre B Hardy; Kathryn M Taylor; Herbert Gaisano; Feihan F Dai; Michael B Wheeler
Journal:  J Biol Chem       Date:  2015-05-12       Impact factor: 5.157

View more
  9 in total

Review 1.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

2.  V-ATPase blockade reduces renal gluconeogenesis and improves insulin secretion in type 2 diabetic rats.

Authors:  Jun Hirao; Akihiro Tojo; Saaya Hatakeyama; Hiroshi Satonaka; Toshihiko Ishimitsu
Journal:  Hypertens Res       Date:  2020-05-08       Impact factor: 3.872

Review 3.  The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome.

Authors:  Nirupama Ramkumar; Donald E Kohan
Journal:  Kidney Int       Date:  2019-02-26       Impact factor: 10.612

4.  The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes.

Authors:  Saifur R Khan; Haneesha Mohan; Ying Liu; Battsetseg Batchuluun; Himaben Gohil; Dana Al Rijjal; Yousef Manialawy; Brian J Cox; Erica P Gunderson; Michael B Wheeler
Journal:  Diabetologia       Date:  2019-01-15       Impact factor: 10.122

Review 5.  Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes.

Authors:  Wen-Juan Jiang; Yun-Chuan Peng; Kai-Ming Yang
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

Review 6.  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.

Authors:  Xiaohong Duan; Shaoqing Yang; Lei Zhang; Tielin Yang
Journal:  Theranostics       Date:  2018-10-26       Impact factor: 11.556

7.  Type 2 Diabetes in the Elderly: Challenges in a Unique Patient Population.

Authors:  David Bradley; Willa Hsueh
Journal:  J Geriatr Med Gerontol       Date:  2016-09-08

Review 8.  The H+-ATPase (V-ATPase): from proton pump to signaling complex in health and disease.

Authors:  Amity F Eaton; Maria Merkulova; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-16       Impact factor: 4.249

9.  Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies.

Authors:  Olivia Wendling; Marie-France Champy; Solène Jaubert; Guillaume Pavlovic; Aline Dubos; Loic Lindner; Hugues Jacobs; Manuel Mark; Roy Combe; Isabelle Goncalves Da Cruz; Hervé Luche; John S Mudgett; Thomas Rosahl; Tania Sorg; Marie Malissen; Patrick T Reilly; Yann Hérault
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.